Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
David T Rubin, Iris Dotan, Aaron DuVall, et al.
Clinical and Translational Gastroenterology
|
January 29, 2021
Randomized, Placebo Controlled Trial of Experimental Hookworm Infection for Improving Gluten Tolerance in Celiac Disease
John Croese, Gregory C Miller, Louise Marquart, et al.
BMJ Open
|
July 2, 2021
Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
Bonita Gu, Michael De Gregorio, Joseph Louis Pipicella, et al.
Gastroenterology
|
April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Mette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
World Journal of Gastroenterology
|
September 3, 2020
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
Samba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease
Rebecca L Roberts, Mary C Wallace, Margien L Seinen, et al.
Journal of Crohn'S & Colitis
|
February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
Emily K Wright, Michael A Kamm, Peter De Cruz, et al.
Journal of Gastroenterology and Hepatology
|
December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's disease
Amy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 26, 2019
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis
Kathryn A Ramsey, Alice C H Chen, Giorgia Radicioni, et al.
Inflammatory Bowel Diseases
|
December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era
Hugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
David T Rubin, Iris Dotan, Aaron DuVall, et al.
Clinical and Translational Gastroenterology
|
January 29, 2021
Randomized, Placebo Controlled Trial of Experimental Hookworm Infection for Improving Gluten Tolerance in Celiac Disease
John Croese, Gregory C Miller, Louise Marquart, et al.
BMJ Open
|
July 2, 2021
Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
Bonita Gu, Michael De Gregorio, Joseph Louis Pipicella, et al.
Gastroenterology
|
April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Mette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
World Journal of Gastroenterology
|
September 3, 2020
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
Samba Siva Reddy Pulusu, Ashish Srinivasan, Krupa Krishnaprasad, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease
Rebecca L Roberts, Mary C Wallace, Margien L Seinen, et al.
Journal of Crohn'S & Colitis
|
February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
Emily K Wright, Michael A Kamm, Peter De Cruz, et al.
Journal of Gastroenterology and Hepatology
|
December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's disease
Amy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 26, 2019
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis
Kathryn A Ramsey, Alice C H Chen, Giorgia Radicioni, et al.
Inflammatory Bowel Diseases
|
December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era
Hugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
Page
of 8